WASHINGTON (dpa-AFX) - OncoGenex Pharmaceuticals, Inc. (OGXI) said Thursday that it commenced a public offering of its common stock.
The company expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering to cover overallotments, if any.
The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering, the company said.
Leerink Swann LLC and Stifel Nicolaus Weisel are acting as joint book-running managers and Lazard Capital Markets LLC and William Blair & Company, L.L.C. are acting as co-managers.
Copyright RTT News/dpa-AFX
© 2012 AFX News
